Erlocip 150mg : What is Erlocip used for? Erlocip tablets 150mg are used to treat non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and grows more slowly than small cell lung cancer (SCLC). NSCLC is associated with a mutation in the gene for Epidermal Growth Factor receptor (EGFR)1 and treatment of NSCLC with Erlocip tablets 150mg is only effective where an EGFR mutation is present in the tumour cells2. Erlocip tablets 150mg are used for treatment of locally advanced (stage III) or metastatic (stage IV) NSCLC either as first-line treatment, as monotherapy maintenance treatment for stable disease after 4 cycles of standard platinum-based first-line chemotherapy or after failure of at least one prior chemotherapy regimen. Erlocip tablets 150mg are also used to treat locally advanced, unresectable (inoperable) or metastatic pancreatic cancer in combination with gemcitabine, an anti-cancer drug used for chemotherapy. Advanced p...